A machine learning approach combining single-lead ECG time-frequency features with a Convolutional Neural Network achieved an average accuracy of 94.6% in classifying patients with advanced rheumatic heart disease.
Cross-Sectional (n=170)
No
Does a machine learning model using single-lead ECG accurately detect advanced rheumatic heart disease compared to healthy controls?
Single-lead ECG combined with machine learning offers a highly accurate, cost-effective tool for detecting advanced rheumatic heart disease in resource-constrained settings.
Effect estimate: Accuracy 94.6%
Rheumatic heart disease (RHD) arises from untreated streptococcal throat infections caused by beta-hemolytic group A streptococci, leading to progressive damage to cardiac valves. While echocardiography is the gold standard for RHD diagnosis, its use in low-income countries is limited due to scarce resources and a lack of trained professionals. Automated RHD detection via echocardiography and phonocardiography data has shown promising, but the effectiveness of electrocardiogram (ECG) for detecting RHD in endemic regions at cardiac wards with limited resource remains uncertain. This study explores the viability of ECG as a cost-effective tool for RHD detection in cardiac wards. The study utilizes a dataset comprising single-lead ECG recordings from 124 confirmed RHD patients and 46 healthy controls collected at a major referral hospital in Ethiopia. Additionally, an extended-RHDECG dataset, which consists of age-matched ECGs from the Physikalisch-Technische Bundesanstalt (PTB-XL) dataset and RHD ECGs, was utilized. A single lead ECG segment of 10-second duration per patient was resampled at 250 Hz. Temporal and relative wavelet energy (RWE) features combined with Convolutional Neural Network (CNN) model features were employed for classification of prevalent cardiovascular diseases in the context of the Global South. A 5-folds cross-validation on RHDECG dataset using CNN model showed an average accuracy (mean ± std) of 88.6 ± 0.2% in detecting RHD from healthy controls. This result was improved with combined features of CNN, temporal and RWE to an average accuracy of 94.6 ± 0.1%. Similar evaluation on extended-RHDECG yielded an accuracy of 54.3 ± 0.3%, which reached to 71.2 ± 0.3% considering the top-2 predictions of the six classes. The RWE concentrations at higher frequency bands were significantly greater in the RHD group than in the healthy control group. The findings suggest that single-lead ECG in combination with machine learning could serve as a potential tool for automatically classifying patients with advanced RHD. ECG time‒frequency features effectively capture abnormalities associated with RHD, enhancing the performance of deep CNN models. This approach offers a cost-effective tool that might be useful in addressing the RHD burden at resource-constrained cardiac clinics in alignment with global health development goals.
Chuma et al. (Mon,) conducted a cross-sectional in Rheumatic heart disease (n=170). Single-lead ECG with machine learning (CNN combined with temporal and RWE features) vs. Healthy controls was evaluated on Classification accuracy for detecting RHD (Accuracy 94.6%). A machine learning approach combining single-lead ECG time-frequency features with a Convolutional Neural Network achieved an average accuracy of 94.6% in classifying patients with advanced rheumatic heart disease.